Turnover of type I and III collagen predicts progression of idiopathic pulmonary fibrosis

by H. Jessen, N. Hoyer, T. S. Prior, P. Frederiksen, M. A. Karsdal, D. J. Leeming, E. Bendstrup, J. M. B. Sand, S. B. Shaker
Published 2021-07-01

A serological marker of the N-terminal neoepitope generated during LOXL2 maturation is elevated in patients with cancer or idiopathic pulmonary fibrosis

by D.J. Leeming, N. Willumsen, J.M.B. Sand, S. Holm Nielsen, B. Dasgupta, C. Brodmerkel, M. Curran, C.L. Bager, MA. Karsdal
Published 2019-03-01

Can biomarkers of extracellular matrix remodelling and wound healing be used to identify high risk patients infected with SARS-CoV-2?: lessons learned from pulmonary fibrosis

by D. J. Leeming, F. Genovese, J. M. B. Sand, D. G. K. Rasmussen, C. Christiansen, G. Jenkins, T. M. Maher, J. Vestbo, M. A. Karsdal
Published 2021-02-01